Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor

Journal of Biological Chemistry

Volumn 287, Issue 43, 2012, Pages 36132-36146

  Ferreras, Cristina ^a   Rushton, Graham ^a   Cole, Claire L ^a   Babur, Muhammad ^a   Telfer, Brian A ^a   Van Kuppevelt, Toin H ^b   Gardiner, John M ^a   Williams, Kaye J ^a   Jayson, Gordon C ^a   Avizienyte, Egle ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANTIANGIOGENIC AGENT; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; HEPARAN SULFATES; IN-VITRO; IN-VIVO; OVARIAN TUMOR; POTENTIAL TARGETS; RECEPTOR SIGNALING; S-DOMAIN; SMOOTH MUSCLE CELLS; STRUCTURAL CHARACTERISTICS; TUBE FORMATION; TUMOR ANGIOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULATURE; WILD TYPES;

SULFUR COMPOUNDS; TUBES (COMPONENTS); TUMORS;

ENDOTHELIAL CELLS;

FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; HEPARAN SULFATE 6 O SULFOTRANSFERASE 1; HEPARAN SULFATE 6 O SULFOTRANSFERASE 2; UNCLASSIFIED DRUG; VASCULOTROPIN 165;

ACETYLATION; AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; OVARIAN VASCULATURE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SULFATION; VASCULARIZATION;

CELLS, CULTURED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPARITIN SULFATE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SULFOTRANSFERASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867827672     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.384875     Document Type: Article

References (39)

1. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8
2. Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. (1992) Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 340, 145-146
3. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401-409 (Pubitemid 24058195)
4. Paley, P. J., Staskus, K. A., Gebhard, K., Mohanraj, D., Twiggs, L. B., Carson, L. F., and Ramakrishnan, S. (1997) Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80, 98-106 (Pubitemid 27270925)
5. Casanovas, O., Hicklin, D. J., Bergers, G., and Hanahan, D. (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299-309 (Pubitemid 41443415)
6. Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W. T., Duda, D. G., Cohen K. S., Kozak, K. R., Cahill, D. P., Chen, P. J., Zhu, M., Ancukiewicz, M., Mrugala, M. M., Plotkin, S., Drappatz, J., Louis, D. N., Ivy, P., Scadden, D. T., Benner, T., Loeffler, J. S., Wen, P. Y., and Jain, R. K. (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11, 83-95 (Pubitemid 46075199)
7. Whitworth, M. K., Backen, A. C., Clamp, A. R., Wilson, G., McVey, R., Friedl, A., Rapraeger, A. C., David, G., McGown, A., Slade, R. J., Gallagher, J. T., and Jayson, G. C. (2005) Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endothelium. Clin. Cancer Res. 11, 4282-4288 (Pubitemid 40825614)
8. Gallagher, J. T. (2006) Multiprotein signaling complexes. Regional assembly on heparan fate. Biochem. Soc. Trans. 34, 438-441
9. Stringer, S. E. (2006) The role of heparan sulfate proteoglycans in angiogenesis. Biochem. Soc. Trans. 34, 451-453
10. Esko, J. D., and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173 (Pubitemid 32656238)
11. Sugahara, K., and Kitagawa, H. (2002) Heparin and heparan sulfate biosynthesis. IUBMB Life 54, 163-175 (Pubitemid 36008325)
12. Ai, X., Do, A. T., Kusche-Gullberg, M., Lindahl, U., Lu, K., and Emerson, C. P., Jr. (2006) Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J. Biol. Chem. 281, 4969-4976 (Pubitemid 43847759)
13. Rosen, S. D., and Lemjabbar-Alaoui, H. (2010) Sulf-2. An extracellular modulator of cell signaling and a cancer target candidate. Expert Opin. Ther. Targets 14, 935-949
14. Lai, J., Chien, J., Staub, J., Avula, R., Greene, E. L., Matthews, T. A., Smith, D. I., Kaufmann, S. H., Roberts, L. R., and Shridhar, V. (2003) Loss of HSulf-1 up-regulates heparin binding growth factor signaling in cancer. J. Biol. Chem. 278, 23107-23117 (Pubitemid 36830377)
15. Narita, K., Staub, J., Chien, J., Meyer, K., Bauer, M., Friedl, A., Ramakrishnan, S., and Shridhar, V. (2006) HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res. 66, 6025-6032
16. Habuchi, H., Nagai, N., Sugaya, N., Atsumi, F., Stevens, R. L., and Kimata, K. (2007) Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J. Biol. Chem. 282, 15578-15588 (Pubitemid 47093285)
17. Turnbull, J. E., Fernig, D. G., Ke, Y., Wilkinson, M. C., and Gallagher, J. T. (1992) Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267, 10337-10341
18. Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U., and Rapraeger, A. C. (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268, 23906-23914 (Pubitemid 23335365)
19. Pye, D. A., Vives, R. R., Turnbull, J. E., Hyde, P., and Gallagher, J. T. (1998) Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J. Biol. Chem. 273, 22936-22942 (Pubitemid 28417468)
20. Cole, C. L., Hansen, S. U., Baráth, M., Rushton, G., Gardiner, J. M., Avizienyte, E., and Jayson, G. C. (2010) Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. PLoS One 5, e11644
21. Robinson, C. J., Mulloy, B., Gallagher, J. T., and Stringer, S. E. (2006) VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J. Biol. Chem. 281, 1731-1740
22. Shively, J. E., and Conrad, H. E. (1976) Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15, 3932-3942
23. Laib, A. M., Bartol, A., Alajati, A., Korff, T., Weber, H., and Augustin, H. G. (2009) Spheroid-based human endothelial cell microvessel formation in vivo. Nat. Protoc. 4, 1202-1215
24. Evensen, L., Micklem, D. R., Blois, A., Berge, S. V., Aarsaether, N., Littlewood- Evans, A., Wood, J., and Lorens, J. B. (2009) Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 4, e5798
25. Lyon, M., Deakin, J. A., Mizuno, K., Nakamura, T., and Gallagher, J. T. (1994) Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 269, 11216-11223
26. Properzi, F., Lin, R., Kwok, J., Naidu, M., van Kuppevelt, T. H., Ten Dam, G. B., Camargo, L. M., Raha-Chowdhury, R., Furukawa, Y., Mikami, T., Sugahara, K., and Fawcett, J. W. (2008) Heparan sulfate proteoglycans in glia and in the normal and injured CNS. Expression of sulfotransferases and changes in sulfation. Eur. J. Neurosci. 27, 593-604 (Pubitemid 351239298)
27. Thompson, S. M., Fernig, D. G., Jesudason, E. C., Losty, P. D., van de Westerlo, E. M., van Kuppevelt, T. H., and Turnbull, J. E. (2009) Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics. Insights into protein binding specificities. J. Biol. Chem. 284, 35621-35631
28. Maccarana, M., Casu, B., and Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J. Biol. Chem. 268, 23898-23905 (Pubitemid 23335364)
29. Kreuger, J., Salmivirta, M., Sturiale, L., Giménez-Gallego, G., and Lindahl, U. (2001) Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J. Biol. Chem. 276, 30744-30752
30. Backen, A. C., Cole, C. L., Lau, S. C., Clamp, A. R., McVey, R., Gallagher, J. T., and Jayson, G. C. (2007) Heparan sulfate synthetic and editing enzymes in ovarian cancer. Br. J. Cancer 96, 1544-1548 (Pubitemid 46762949)
31. Fuster, M. M., Wang, L., Castagnola, J., Sikora, L., Reddi, K., Lee, P. H., Radek, K. A., Schuksz, M., Bishop, J. R., Gallo, R. L., Sriramarao, P., and Esko, J. D. (2007) Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J. Cell Biol. 177, 539-549 (Pubitemid 46718281)
32. Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson, I., Kjellén, L., and Claesson-Welsh, L. (2006) Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 10, 625-634
33. Hiscock, D. R., Canfield, A., and Gallagher, J. T. (1995) Molecular structure of heparan sulfate synthesised by bovine aortic endothelial cells. Biochim. Biophys. Acta 1244, 104-112
34. Pye, D. A., and Kumar, S. (1995) Molecular attributes of bovine aortic endothelial cell heparan sulfate. Biochim. Biophys. Acta 1266, 235-244
35. Jastrebova, N., Vanwildemeersch, M., Lindahl, U., and Spillmann, D. (2010) Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling. J. Biol. Chem. 285, 26842-26851
36. Kan, M., Wu, X., Wang, F., and McKeehan, W. L. (1999) Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J. Biol. Chem. 274, 15947-15952
37. Pellegrini, L. (2001) Role of heparan sulfate in fibroblast growth factor signaling. A structural view. Curr. Opin. Struct. Biol. 11, 629-634
38. Goodger, S. J., Robinson, C. J., Murphy, K. J., Gasiunas, N., Harmer, N. J., Blundell, T. L., Pye, D. A., and Gallagher, J. T. (2008) Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J. Biol. Chem. 283, 13001-13008
39. Boilly, B., Vercoutter-Edouart, A. S., Hondermarck, H., Nurcombe, V., and Le Bourhis, X. (2000) FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev. 11, 295-302